Your browser doesn't support javascript.
loading
Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer.
Ogino, Misato; Fujii, Takaaki; Koibuchi, Yukio; Nakazawa, Yuko; Takata, Daisuke; Shirabe, Ken.
Afiliação
  • Ogino M; Division of Breast and Endocrine Surgery, and.
  • Fujii T; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Gunma, Japan.
  • Koibuchi Y; Department of Breast and Endocrine Surgery, National Hospital Organization Takasaki General Medical Center, Gunma, Japan.
  • Nakazawa Y; Division of Breast and Endocrine Surgery, and ftakaaki@gunma-u.ac.jp.
  • Takata D; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Gunma, Japan.
  • Shirabe K; Department of Breast and Endocrine Surgery, National Hospital Organization Takasaki General Medical Center, Gunma, Japan.
Anticancer Res ; 41(8): 3899-3904, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34281852

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Antineoplásicos Alquilantes / Ciclofosfamida / Albuminas / Trastuzumab / Antineoplásicos Imunológicos / Antineoplásicos Fitogênicos Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Antineoplásicos Alquilantes / Ciclofosfamida / Albuminas / Trastuzumab / Antineoplásicos Imunológicos / Antineoplásicos Fitogênicos Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2021 Tipo de documento: Article